Pandox AB (publ) interim report January–March 2019
Sustained profitable growth
January–March 2019
- Revenue from Property Management amounted to MSEK 685 (621). The increase for comparable units was 1.3 percent, adjusted for currency effects
- Net operating income from Property Management amounted to MSEK 583 (528), MSEK 568 excluding the effects of IFRS 16. The increase for comparable units was 1.3 percent, adjusted for currency effects
- Net operating income from Operator Activities amounted to MSEK 95 (66), MSEK 90 excluding the effects of IFRS 16. The increase for comparable units was 17.1 percent, adjusted for currency effects
- Calendar effects are estimated to have had a positive effect on revenue growth of 2-3 percent in the comparable portfolio
- EBITDA amounted to MSEK 634 (560), MSEK 615 excluding the effects of IFRS 16
- Cash earnings amounted to MSEK 362 (336)
- Cash earnings per share amounted to SEK 2.16 (2.00)
- Profit for the period amounted to MSEK 407 (452)
- Earnings per share amounted to SEK 2.43 (2.69)
Attachment: Interim report January–March 2019
FOR FURTHER INFORMATION, PLEASE CONTACT:
Anders Nissen, CEO, +46 (0) 708 46 02 02
Liia Nõu, CFO, +46 (0) 702 37 44 04
Anders Berg, Head of Communications and IR, +46 (0) 760 95 19 40
This information is information that Pandox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above 26 April 2019 at 07:00 CEST.
About Pandox
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 144 hotels with approximately 32,300 hotel rooms in fifteen countries. Pandox’s business is organised into Property Management, which comprises hotel properties leased on a long-term basis to leading hotel operators, and Operator Activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are listed on Nasdaq Stockholm. www.pandox.se
Tags: